| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ars Pharmaceuticals, Inc. (SPRY) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. SPRY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.89M | $47.16M | - | |
| Dir | 4.47M | $43.18M | - | |
| Other | 240.0K | $2.32M | - | |
| Other | 240.0K | $2.32M | - | |
| CEO | 240.0K | $2.32M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 20, 2025 | Fitzpatrick Alexander A81 | Chief Legal Officer | Sale+OE | 102,969 | $14.10 | $1,451,512.81 | -53.5% | -2.1% | -45.6% | |
| May 20, 2025 | Scott Kathleen D.64 | Chief Financial Officer | Sale+OE | 50,000 | $14.10 | $705,165.00 | -87.1% | -2.1% | -45.6% | |
| May 20, 2025 | Saunders Brent L51 | Director | Sale+OE | 120,000 | $14.25 | $1,710,024.00 | -100% | -2.1% | -45.6% | |
| Apr 7, 2025 | Shawver Laura56 | Director | Sale+OE | 50,002 | $12.30 | $615,074.60 | -19.2% | +33.2% | -36.5% | |
| Mar 20, 2025 | Karas Eric75 | Chief Commercial Officer | Sale+OE | 10,000 | $14.00 | $140,000.00 | -56.5% | +11.2% | -42.9% | |
| Mar 6, 2025 | Shawver Laura56 | Director | Sale+OE | 50,000 | $11.21 | $560,445.76 | -10.6% | +28.1% | -16.0% | |
| Feb 3, 2025 | Shawver Laura56 | Director | Sale+OE | 50,000 | $12.31 | $615,565.00 | -19.2% | +15.8% | -17.5% | |
| Jan 6, 2025 | Shawver Laura56 | Director | Sale+OE | 50,000 | $11.10 | $555,065.00 | -19.2% | +15.8% | +0.6% | |
| Dec 17, 2024 | Tanimoto Sarina54 | Chief Medical Officer | Sell | 100,000 | $11.67 | $1,167,100.00 | -4.0% | -2.7% | -14.4% | |
| Dec 17, 2024 | Lowenthal Richard E54 | President And CEO | Sell | 100,000 | $11.67 | $1,167,100.00 | -4.0% | -2.7% | -14.4% |